Real-World Effectiveness and Safety of Saccharomyces boulardii CNCM I-745 as Adjunct Therapy for Helicobacter pylori Eradication: Data From the European Registry on H. pylori Management (Hp-EuReg)

Helicobacter Pylori

Long-Term Effect of Macrolides on Helicobacter pylori Eradication: Data From the European Registry on Helicobacter pylori Management (Hp-EuReg)

Helicobacter

Nyssen OP, Ortega GJ, Jonaitis L, Pérez-Aísa Á, Tepes B, Lucendo AJ, Tejedor-Tejada J, Bumane R, Garre A, Huguet JM, Perona M, Núñez Ó, Pabón-Carrasco M, Castro-Fernández M, Areia M, Barrio J, Loro AM, Butler TJ, Marcos MS, Keco-Huerga A, Cajal MD, Denkovski M, Pavoni M, Buzás GM, Lerang F, Losurdo G, Wolfe García PM, Phull PS, Martínez-Domínguez SJ, Kupcinskas J, Leja M, Marcos-Pinto R, Smith SM, Gasbarrini A, Papp V, Rodríguez BJG, Alonso MS, Villarroya RP, Mejide PP, Jiménez-Moreno M, Pascual-Mato M, Bravo-Pache C, Montes M, Cano-Català A, Parra P, Moreira L, Mégraud F, O'Morain C, Bujanda L, Gisbert JP, Hp‐EuReg investigators

doi: 10.1111/hel.70107

Helicobacter Pylori

Second- and Third-Line Therapies for Helicobacter pylori Eradication in Slovenia: Data From 2013-2023 of the European Registry on H. pylori Management

Helicobacter

Tepes B, Denkovski M, Jurecic NB, Tepes K, Cano-Català A, Parra P, Moreira L, Nyssen OP, Mégraud F, O'Morain C, Gisbert JP

doi: 10.1111/hel.70085

Helicobacter Pylori

An Open-Label Randomized Controlled Trial Comparing the Efficacy and Safety of a 7-Day Triple Therapy With Bismuth Versus 14-Day Standard Triple Therapy for Helicobacter pylori Eradication in Children and Adolescents

Helicobacter

Šterbenc A, Vratanar B, Mojškerc EM, Homan M

doi: 10.1111/hel.70103

Inflammatory Bowel Disease

Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida Registry

United European Gastroenterol J

Iborra M, Botella B, Martín-Arranz MD, Ceballos D, Martínez-Pascual C, Garrido A, Varela P, Moreta M, Brunet-Mas E, González-Lama Y, Rodríguez-González E, Vicuña M, Gisbert JP, Ordás I, Argüelles-Arias F, Tosca-Cuquerella J, Vicente-Lidón R, Sierra-Ausín M, Rodríguez-Lago I, Martín-Rodríguez D, Paredes JM, Sicilia B, García de la Filia I, Jiménez N, Barreiro-de Acosta M, Betoré E, Ferrer-Bradley I, García-Alles L, Huguet JM, Castellet-Farrús S, García MJ, Gutiérrez-Casbas A, Ponferrada-Díaz Á, Ramos L, Calafat M, Vera I, Suárez-Ferrer C, Fernández-Velado E, Rodríguez-Sánchez S, Mínguez A, Mancebo A, Barrio J, Lario S, de La Cruz DR, Hernández-Camba A, Rodríguez-Gutiérrez C, Chaparro M, Ricart E, Almenara-Michelena L, Balaguer A, Domènech E, Nos P

doi: 10.1002/ueg2.70223

Helicobacter Pylori

Efficacy and Safety of Tegoprazan-Based Dual, Triple, and Quadruple Therapies in First-Line Helicobacter pylori Eradication: A Prospective Randomized Controlled Trial

Helicobacter

Zhu YC, Li K, Sun A, Lin S, Zhang J, Meng S, Xia X, Gao H, Lin J, Jiang W

doi: 10.1111/hel.70147

Helicobacter Pylori

High Eradication Rate of a Potassium-Competitive Acid Blocker-Based Minocycline, Furazolidone, and Bismuth Regimen for Refractory Helicobacter pylori Infection: A Real-World Study

Helicobacter

Li JY, Han YY, Li DY, Liu JM, Zhou ZZ, Zhou YN, Tuo L, Yao XJ, Liu M, Wang G, Li PY

doi: 10.1111/hel.70128

Helicobacter Pylori

Efficacy and Safety of Fexuprazan-Based Modified High-Dose Dual Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial

Helicobacter

Ahn JY, Shim KN, Park JH, Kim SG, Kim JH, Moon JS, Youn YH, Kim JJ

doi: 10.1111/hel.70146

Helicobacter Pylori

Efficacy and Safety of Vonoprazan-Based Dual, Triple, and Quadruple Therapies for Helicobacter pylori Eradication: A Randomized Controlled Trial

Helicobacter

Zhang JY, Li J, Huang WF, Lei XY, Huang YL, Xu GH, Xu D

doi: 10.1111/hel.70112

Helicobacter Pylori

Efficacy and Safety of Quadruple Therapy With Semisynthetic Tetracycline for Helicobacter pylori Eradication: A Meta-Analysis

J Gastroenterol Hepatol

Guo QQ, Zhang J, Zhu XJ, Li WY, Zhao DY, Liang MQ, Yan R, Shi YQ

doi: 10.1111/jgh.70348

Related content

Long-Term Effect of Macrolides on Helicobacter pylori Eradication: Data From the European Registry on Helicobacter pylori Management (Hp-EuReg)

Second- and Third-Line Therapies for Helicobacter pylori Eradication in Slovenia: Data From 2013-2023 of the European Registry on H. pylori Management

An Open-Label Randomized Controlled Trial Comparing the Efficacy and Safety of a 7-Day Triple Therapy With Bismuth Versus 14-Day Standard Triple Therapy for Helicobacter pylori Eradication in Children and Adolescents

Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida Registry

Efficacy and Safety of Tegoprazan-Based Dual, Triple, and Quadruple Therapies in First-Line Helicobacter pylori Eradication: A Prospective Randomized Controlled Trial

High Eradication Rate of a Potassium-Competitive Acid Blocker-Based Minocycline, Furazolidone, and Bismuth Regimen for Refractory Helicobacter pylori Infection: A Real-World Study

Efficacy and Safety of Fexuprazan-Based Modified High-Dose Dual Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial

Efficacy and Safety of Vonoprazan-Based Dual, Triple, and Quadruple Therapies for Helicobacter pylori Eradication: A Randomized Controlled Trial

Efficacy and Safety of Quadruple Therapy With Semisynthetic Tetracycline for Helicobacter pylori Eradication: A Meta-Analysis